Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia [NA]

View source ↗

Summary

A completed clinical trial evaluating fermented soybean supplementation in active pulmonary tuberculosis patients on standard therapy; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • fermented soybean supplementation

Snippet

Sponsor: University of Giessen | Conditions: Pulmonary Tuberculosis, Body Weight Changes | NA | Status: COMPLETED | Results posted: 2022-06-21